- Home
- ESEA vs OCGN Comparison
ESEA vs OCGN Comparison
Compare ESEA & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESEA
- OCGN
- Stock Information
- Founded
- ESEA 2005
- OCGN 2013
- Country
- ESEA Greece
- OCGN United States
- Employees
- ESEA N/A
- OCGN N/A
- Industry
- ESEA Marine Transportation
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ESEA Consumer Discretionary
- OCGN Health Care
- Exchange
- ESEA Nasdaq
- OCGN Nasdaq
- Market Cap
- ESEA 253.9M
- OCGN 229.2M
- IPO Year
- ESEA 2006
- OCGN N/A
- Fundamental
- Price
- ESEA $33.83
- OCGN $0.68
- Analyst Decision
- ESEA Buy
- OCGN Strong Buy
- Analyst Count
- ESEA 1
- OCGN 3
- Target Price
- ESEA $53.00
- OCGN $6.00
- AVG Volume (30 Days)
- ESEA 31.6K
- OCGN 3.5M
- Earning Date
- ESEA 03-04-2025
- OCGN 03-05-2025
- Dividend Yield
- ESEA 7.09%
- OCGN N/A
- EPS Growth
- ESEA 3.12
- OCGN N/A
- EPS
- ESEA 16.28
- OCGN N/A
- Revenue
- ESEA $208,648,067.00
- OCGN $4,700,000.00
- Revenue This Year
- ESEA $13.72
- OCGN N/A
- Revenue Next Year
- ESEA $3.06
- OCGN N/A
- P/E Ratio
- ESEA $2.08
- OCGN N/A
- Revenue Growth
- ESEA 13.90
- OCGN N/A
- 52 Week Low
- ESEA $30.21
- OCGN $0.64
- 52 Week High
- ESEA $50.92
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- ESEA 51.50
- OCGN 40.75
- Support Level
- ESEA $33.17
- OCGN $0.67
- Resistance Level
- ESEA $34.89
- OCGN $0.76
- Average True Range (ATR)
- ESEA 1.24
- OCGN 0.04
- MACD
- ESEA 0.28
- OCGN 0.00
- Stochastic Oscillator
- ESEA 64.07
- OCGN 28.57
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").